Market Tracker

10/22 3:43am ET

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

1.35
Data as of Oct 21
 +0.03 / +2.27%
Today’s Change
1.04
Today|||52-Week Range
2.62
-24.96%
Year-to-Date

Today’s Trading

Previous close1.32
Today’s open1.32
Day’s range-- - --
Volume1,123,831
Average volume (3 months)857,073
Market cap$679.6M
Dividend yield--
Data as of 10/21/2014

Growth & Valuation

Earnings growth (last year)+13.04%
Earnings growth (this year)-3.12%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)+104.04%
P/E ratioNM
Price/Sales415.44
Price/Book3.98

Competitors

 Today’s
change
Today’s
% change
AMRIAlbany Molecular Res...+0.59+2.70%
SGMOSangamo BioSciences ...-0.18-1.68%
BRLIBio-Reference Labora...-0.02-0.07%
NXTMNxStage Medical Inc+0.36+2.56%
Data as of 3:59pm ET, 10/21/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$2.2M
Annual profit (last year)-$104.1M
Net profit margin-4,686.14%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
VP-Marketing, Commercial Strategy &
Operations
John Northcott
Corporate headquarters
The Woodlands, Texas

Forecasts